Lek once again recognized as the most reputable employer
- Lek has received the flattering title of the most reputable employer for the third year in a row and for the fourth time overall.
- The title of the most reputable employer is awarded by the recruitment portal MojeDelo.com, which evaluates the reputation of Slovenian companies among the candidates on the labor market.
- Lek is renowned for its unbossed culture that embraces innovation, curiosity, diversity, and inclusiveness.
Once again and for the third time in a row, Lek has been chosen as the most reputable employer in Slovenia according to the participants of MojeDelo.com portal’s evaluation of employers’ reputation. In the research, candidates in the labor market selected Lek as the absolute winner and the winner in all individual categories.
The award was accepted on behalf of Lek by Robert Ljoljo, President of the Board of Management of Lek and Novartis Country President Slovenia. In his acceptance speech, he emphasized the well-coordinated and dedicated team that is behind the title of the most reputable employer: “The biggest thanks go to all our associates with whom we are building our reputation every day. For many of us, including me, Lek is the first and only employer of our career. That alone is already a special kind of praise for the company as an employer. The title of the most reputable employer thus confirms that we have made the right decision and that together we are creating a unique story. This story is based on strong values of innovation, courage, integrity and diversity and inclusiveness. We are building a solid and inspiring culture of curious and motivated associates, who are a prerequisite for the development and success of the company. Our goal is to create a work environment for every individual that will enable them to unleash their talent and creativity and reach their potential. By accepting and encouraging diversity, we are operating in an environment of continuous learning, cooperation, and mutual motivation to become the best versions of ourselves.”
Lek has made substantial investments into improving the work environment to fit the individuals. Hybrid forms of work enable employees to decide for themselves, according to the nature of their work, how, where and when they perform their work. Their efforts towards creating a modern work environment are supported by investments into new, advanced working practices with active working solutions. They rely on digitalization, smart solutions, and mixed and augmented reality, which enables the agility and efficiency needed for fulfilling their mission, to care for patients worldwide.
Novartis is the leading provider of medicines in Slovenia, where Lek d.d.,Novartis Pharma Services Inc. and Sandoz d.d., operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role inNovartis' organizational structure, especially in the Novartis TechnicalOperations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees.Novartis invested in Slovenia more than EUR 3 billion since 2003.
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2021 sales of USD 9.6 billion.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
This press release contains statements and forecasts of future business operations. The forecasts include estimates based on all the information currently available to us. Should these forecasts prove unreliable, the actual results of business operations could be different from those expected.
Forfurther information, please contact:
Communication & External Engagement
Lek Pharmaceuticals d.d.
Telephone: 01 580 22 43